The results from the GSCA database showed that there was a significant positive correlation between the expression of FAM110A and CNV in patients with COAD, BRCA, HNSC, and LUAD; in contrast, the correlations were not significant in patients with LAML, THCA, GBM, uveal melanoma (UVM), THYM, KICH, KIRC, PCPG, sarcoma (SARC), and DLBC (Figure 3A), suggesting that CNV may not be the only factor responsible for abnormal FAM110A expression, and the underlying mechanisms leading to aberrant expression may be inconsistent in different tumors. The gene discussed is FAM110A; the disease is sarcoma.